Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and PRF after open carpal tunnel release
IRCT20261006071309N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma and platelet rich fibrin in carpal tunnel syndrome (CTS) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Improvement of clinical symptoms, Wound healing and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
platelet-rich plasmaplatelet rich fibrin
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20261006071309N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261006071309N1.